{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:06:58Z","timestamp":1789020418472,"version":"build-2803163510"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Resistant arterial hypertension (RAH) is associated with a high burden of cardiovascular complications, particularly coronary heart disease (CHD). MicroRNAs (miRNAs) are important regulators of cardiovascular remodeling and metabolic dysfunction; however, data regarding peripheral blood mononuclear cell (PBMC) miRNA expression in patients with RAH and concomitant CHD remain limited. This study aimed to evaluate PBMC miRNA expression profiles associated with CHD in patients with RAH and to explore their relationship with metabolic abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this cross-sectional study, 115 patients with RAH were enrolled. PBMCs were isolated from peripheral blood and expression levels of selected microRNAs were quantified using TaqMan-based quantitative real-time PCR. Relative expression was calculated using the 2\n                      <jats:sup>\u2212\u0394\u0394CT<\/jats:sup>\n                      method and expressed as log-transformed relative quantification (logRQ). Patients were stratified according to the presence of CHD. Correlation analyses, subgroup comparisons, and receiver operating characteristic (ROC) analyses were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with patients with isolated RAH, those with concomitant CHD exhibited significantly higher PBMC expression levels of miR-195 (p = 0.0148), miR-26b (p = 0.0166), miR-208 (p = 0.0435), and miR-320 (p = 0.0402). These microRNAs demonstrated strong positive intercorrelations, indicating a coordinated expression pattern. Within the CHD subgroup, expression levels of all four microRNAs were significantly higher in patients with type 2 diabetes (T2D) and positively correlated with glycated hemoglobin and body mass index. ROC analysis demonstrated modest discriminative ability for identifying T2D within the CHD subgroup, with the highest performance observed for miR-195 (AUC = 0.706).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with RAH and concomitant CHD exhibit a distinct PBMC microRNA expression profile characterized by increased expression of miR-195, miR-208, miR-26b, and miR-320. The association of these microRNAs with T2D and markers of metabolic dysfunction suggests that they may reflect the combined cardiovascular and metabolic disease burden in patients with advanced hypertension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmolb.2026.1905966","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:33:00Z","timestamp":1789018380000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNA expression profile associated with coronary heart disease in patients with resistant arterial hypertension"],"prefix":"10.3389","volume":"13","author":[{"given":"Robert Tomasz","family":"B\u0142aszczyk","sequence":"first","affiliation":[{"name":"Department of Cardiology, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Petniak","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Bogucki","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, John Paul II Catholic University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Kocki","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Wi\u015bniowski","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"G\u0142owniak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Lublin","place":["Lublin, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"H603","DOI":"10.1152\/ajpheart.00681.2024","article-title":"Emerging roles of noncoding RNAs in cardiovascular pathophysiology","volume":"328","author":"Abbas","year":"2025","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12933-023-01965-7","article-title":"The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction","volume":"22","author":"An","year":"2023","journal-title":"Cardiovasc Diabetol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.12688\/f1000research.4884.4","article-title":"MicroRNA levels quantified in whole blood vary from PBMCs","volume":"3","author":"Atarod","year":"2014","journal-title":"F1000Res"},{"key":"B4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/B978-0-323-88369-6.00047-5","article-title":"Resistant hypertension","volume-title":"Hypertension","author":"Azizi","year":"2024"},{"key":"B5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/jcm13020542","article-title":"Association between resistant arterial hypertension, type 2 diabetes and selected microRNAs","volume":"13","author":"B\u0142aszczyk","year":"2024","journal-title":"J. Clin. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e952860","DOI":"10.12659\/MSM.952860","article-title":"Association of miR-133a with microalbuminuria in patients with resistant arterial hypertension and chronic kidney disease","volume":"32","author":"B\u0142aszczyk","year":"2026","journal-title":"Med. Sci. Monit."},{"key":"B7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41569-024-01001-5","article-title":"Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease","volume":"21","author":"Caporali","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/joim.12921","article-title":"Circulating microRNAs in suspected stable coronary artery disease: a coronary computed tomography angiography study","volume":"286","author":"de Gonzalo-Calvo","year":"2019","journal-title":"J. Intern Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"6661","DOI":"10.3390\/ijms25126661","article-title":"Hypertension and heart failure: from pathophysiology to treatment","volume":"25","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/ajh\/hpx197","article-title":"Noncoding RNAs in cardiovascular disease: pathological relevance and emerging role as biomarkers and therapeutics","volume":"31","author":"Gangwar","year":"2018","journal-title":"Am. J. Hypertens."},{"key":"B11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ejhf.2493","article-title":"Cardiac remodelling\u2014part 1: from cells and tissues to circulating biomarkers. A review from the study group on biomarkers of the heart failure association of the european society of cardiology","volume":"24","author":"Gonz\u00e1lez","year":"2022","journal-title":"Eur. J. Heart Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.124.21728","article-title":"MicroRNA and hypertension","volume":"82","author":"He","year":"2025","journal-title":"Hypertension"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00125-010-1667-2","article-title":"Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes","volume":"53","author":"Herrera","year":"2010","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bbrc.2010.03.075","article-title":"The peripheral blood mononuclear cell microRNA signature of coronary artery disease","volume":"394","author":"Hoekstra","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e033674","DOI":"10.1161\/JAHA.123.033674","article-title":"Plasma extracellular microRNAs associated with cardiovascular disease risk factors in middle-aged and older adults","volume":"13","author":"Karlin","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/cvr\/cvz302","article-title":"Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease","volume":"116","author":"Kaur","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6430","DOI":"10.3390\/ijms25126430","article-title":"MicroRNA expression in patients with coronary artery disease and hypertension: a systematic review","volume":"25","author":"Kondracki","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jash.2015.07.013","article-title":"Hypertrophic and antihypertrophic microRNA levels in peripheral blood mononuclear cells and their relationship to left ventricular hypertrophy in patients with essential hypertension","volume":"9","author":"Kontaraki","year":"2015","journal-title":"J. Am. Soc. Hypertens."},{"key":"B19","doi-asserted-by":"publisher","first-page":"653","DOI":"10.17816\/brmma465745","article-title":"Resistant arterial hypertension: modern view of the problem","volume":"25","author":"Kuchmin","year":"2023","journal-title":"Vestn. Ross. Voen. Med. Akad."},{"key":"B20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.7150\/ijbs.50906","article-title":"The role of miR-320 in glucose and lipid metabolism disorder-associated diseases","volume":"17","author":"Li","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/j.1440-1681.2009.05207.x","article-title":"Changes in microRNA (miR)-320 profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes","volume":"36","author":"Ling","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"ESH guidelines for the management of arterial hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension and the European Renal Association","volume":"41","author":"Mancia","year":"2023","journal-title":"J. Hypertens."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41127","DOI":"10.1038\/srep41127","article-title":"Selection of reference genes is critical for miRNA expression analysis in human cardiac tissue: a focus on atrial fibrillation","volume":"7","author":"Mas\u00e8","year":"2017","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1093\/cvr\/cvaf234","article-title":"MicroRNA-26b\u2212\/\u2212 augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis","volume":"121","author":"Peters","year":"2025","journal-title":"Cardiovasc Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.15713\/ins.johtn.0191","article-title":"The perplexing problem of resistant hypertension: evaluation and treatment","volume":"6","author":"Pinto","year":"2020","journal-title":"Hypertens. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"18438","DOI":"10.1038\/s41598-023-45146-8","article-title":"Peripheral blood mononuclear cell expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis","volume":"13","author":"Saadatian","year":"2023","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1002\/jcb.29557","article-title":"Peripheral blood mononuclear cell microRNAs in coronary artery disease","volume":"121","author":"Sanlialp","year":"2020","journal-title":"J. Cell Biochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e079108","DOI":"10.1136\/bmj-2023-079108","article-title":"Diagnosis and management of resistant hypertension","volume":"385","author":"Schiffrin","year":"2024","journal-title":"BMJ"},{"key":"B32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11886-023-02014-1","article-title":"MicroRNAs and cardiovascular disease risk","volume":"26","author":"Searles","year":"2024","journal-title":"Curr. Cardiol. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.33963\/v.phj.103994","article-title":"Circulatory microRNAs in acute coronary syndrome: an update","volume":"82","author":"Stojkovic","year":"2024","journal-title":"Kardiol. Pol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ncrna.2024.11.004","article-title":"The functions of immune system-derived miRNAs in cardiovascular diseases","volume":"11","author":"Sufianov","year":"2025","journal-title":"Noncoding RNA Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/ijms24010616","article-title":"MicroRNAs as biomarkers for coronary artery disease related to type 2 diabetes mellitus\u2014from pathogenesis to potential clinical application","volume":"24","author":"Szyde\u0142ko","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/ijo.2015.95","article-title":"MiR-26b modulates insulin sensitivity in adipocytes by interrupting the PTEN\/PI3K\/AKT pathway","volume":"39","author":"Xu","year":"2015","journal-title":"Int. J. Obes. (Lond)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s11010-024-04947-9","article-title":"The pharmaco-epigenetics of hypertension: a focus on microRNA","volume":"479","author":"Yaacoub","year":"2024","journal-title":"Mol. Cell Biochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.14744\/AnatolJCardiol.2018.43255","article-title":"Combination of peripheral blood mononuclear cell miR-19b-5p, miR-221, miR-25-5p, and hypertension correlates with an increased heart failure risk in coronary heart disease patients","volume":"20","author":"Yao","year":"2018","journal-title":"Anatol. J. Cardiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"108004","DOI":"10.1016\/j.diabres.2020.108004","article-title":"The functions of microRNA-208 in the heart","volume":"160","author":"Zhao","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/cvr\/cvr145","article-title":"MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1","volume":"92","author":"Zhu","year":"2011","journal-title":"Cardiovasc Res."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1905966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:33:01Z","timestamp":1789018381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1905966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":41,"alternative-id":["10.3389\/fmolb.2026.1905966"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1905966","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1905966"}}